Sol Efroni
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 20
- T-cell and B-cell Immunology 17
- Immunotherapy and Immune Responses 4
-
- Bioinformatics and Genomic Networks 10
- Single-cell and spatial transcriptomics 5
- vaccines and immunoinformatics approaches 4
- Co-authors
- Rotem Ben‐Hamo (24 shared papers)Irun R. Cohen (12 shared papers)Kenneth H. Buetow (6 shared papers)Eran Meshorer (5 shared papers)Yoram Louzoun (4 shared papers)David Harel (7 shared papers)Tom Misteli (3 shared papers)Jennifer I. C. Benichou (2 shared papers)
- Journals
- Scientific Reports (4 papers)Oncotarget (4 papers)PLoS Computational Biology (4 papers)PLoS ONE (3 papers)Nature Communications (3 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Sol Efroni
78 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 366
- Immunology 457
- Molecular Biology 1.3k
- Geriatrics and Gerontology 47
- Oncology 278
Countries citing papers authored by Sol Efroni
This map shows the geographic impact of Sol Efroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sol Efroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sol Efroni more than expected).
Fields of papers citing papers by Sol Efroni
This network shows the impact of papers produced by Sol Efroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sol Efroni. The network helps show where Sol Efroni may publish in the future.
Co-authors
The 25 scholars most cited alongside Sol Efroni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 526 | |
| 2 | 2013 | 295 | |
| 3 | 2011 | 185 | |
| 4 | 2016 | 150 | |
| 5 | 2010 | 119 | |
| 6 | 2018 | 119 | |
| 7 | 2019 | 114 | |
| 8 | 2007 | 106 | |
| 9 | 2015 | 75 | |
| 10 | 2015 | 73 | |
| 11 | 2012 | 72 | |
| 12 | 2020 | 72 | |
| 13 | 2005 | 67 | |
| 14 | 2007 | 65 | |
| 15 | 2015 | 57 | |
| 16 | 2015 | 55 | |
| 17 | 2018 | 52 | |
| 18 | 2014 | 50 | |
| 19 | 2001 | 46 | |
| 20 | 2015 | 41 |
About Sol Efroni
Sol Efroni is a scholar working on Immunology, Molecular Biology, Cancer Research, Oncology and Biomedical Engineering, having authored 82 papers that have together received 3.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (17 papers), Bioinformatics and Genomic Networks (10 papers), Artificial Immune Systems Applications (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), MicroRNA in disease regulation (5 papers), Single-cell and spatial transcriptomics (5 papers), vaccines and immunoinformatics approaches (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Cancer Research (366 citations), Immunology (457 citations), Molecular Biology (1.3k citations), Geriatrics and Gerontology (47 citations) and Oncology (278 citations). Sol Efroni has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Rotem Ben‐Hamo, Irun R. Cohen, Kenneth H. Buetow, Eran Meshorer, Yoram Louzoun, David Harel, Tom Misteli, Jennifer I. C. Benichou, Carl F. Schaefer and T Gingeras. Their work appears in journals such as Scientific Reports, Oncotarget, PLoS Computational Biology, PLoS ONE and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.